Structural vaccinology for melioidosis vaccine design and immunodiagnostics

Purpose of Review
Spurred by the successful application of structural vaccinology to other challenging bacterial and viral pathogens, we review the possibility of exploiting 3D structure computational-based recombinant antigen engineering strategies for the development of a protective melioidosis vaccine.
Recent Findings
Structure-based epitope design approaches in the melioidosis field are preliminary and applied essentially by one research network. By combining Burkholderia pseudomallei antigen 3D structures and in silico epitope discovery methods, a panel of synthetic epitope peptides were designed and tested for their B and T cell stimulatory activities. Several peptides were found to be serodiagnostic for B. pseudomallei infection and two elicited bactericidal antibodies.
Summary
A significant amount of B. pseudomallei antigen structures, epitopes, and immunological data is available. Future challenges will be to test all available B. pseudomallei epitopes, focusing on combing multiple B/T cell epitopes onto a single scaffold to generate components, stimulating both arms of the immune system.